Vocan Biotechnologies

Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds

GMP Drug Inc., a wholly-owned subsidiary of Core One Labs Inc. (OTCQB: CLABF) (CSE:COOL)(Frankfurt:LD6) (WKN: A3CSSU) has entered into a non-binding letter of intent with Zollaris Laboratories Corporation, an arms-length party, in pursuit of a potential transaction involvin

Psyched: The First Psychedelics ETF, Beckley Raises $19M, 3 Companies Go Public

The Psychedelics Sector Might Soon Get Its First ETF Financial services company Horizons ETFs Management filed documents with the Ontario Securities Commission for a psychedelics ETF, which is expected to go live on Jan. 15.